An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...

The market competition, managed care, and ‘corporate efficiency’ that economists prescribed as the cure for health care ...

After tense negotiations, Gilead Sciences has agreed not to boost prices next year for HIV medicines that are sold to state ...

The ADA is the basis of an agreement that keeps North Carolina nursing centers from excluding all people with addiction ...

Despite the mechanisms that made it a “biologically plausible” candidate, the study found that participants who took the drug ...

Competitive bidding for catheters means reduced patient choice, jeopardized supply chains, and an incentive to push cheap, ...

The American Medical Association announced a new Center for Digital Health and AI. In a Q&A, AMA CEO John Whyte discusses its ...

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Announcements from Abridge and OpenEvidence at HLTH highlight how the once distinct artificial intelligence startups are now ...

FDA drug approvals dropped in the third quarter, more marketing applications were rejected than in previous months, and more ...

One of the greatest lessons of the last five years is that public health needs to step up its game in dealing with ...